INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $844,000 | +15.0% | 49,421 | -8.0% | 0.00% | 0.0% |
| Q4 2018 | $734,000 | -76.9% | 53,747 | -51.6% | 0.00% | 0.0% |
| Q3 2018 | $3,180,000 | +90.1% | 111,134 | +81.8% | 0.00% | 0.0% |
| Q2 2018 | $1,673,000 | +113.7% | 61,133 | +64.6% | 0.00% | 0.0% |
| Q1 2018 | $783,000 | +0.8% | 37,147 | -8.1% | 0.00% | 0.0% |
| Q4 2017 | $777,000 | -18.5% | 40,415 | +5.4% | 0.00% | 0.0% |
| Q3 2017 | $953,000 | -14.1% | 38,339 | -44.7% | 0.00% | 0.0% |
| Q2 2017 | $1,110,000 | +302.2% | 69,349 | +253.9% | 0.00% | – |
| Q1 2017 | $276,000 | -17.1% | 19,595 | -22.9% | 0.00% | – |
| Q4 2016 | $333,000 | -5.9% | 25,420 | +22.1% | 0.00% | – |
| Q3 2016 | $354,000 | -17.7% | 20,814 | +3.4% | 0.00% | – |
| Q2 2016 | $430,000 | – | 20,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |